Article Information
PubMed
Published By
History
- Received December 4, 2013
- Revision received March 7, 2014
- Accepted March 29, 2014
- First published May 7, 2014.
- Version of record published May 7, 2014.
Copyright & Usage
Copyright © 2014 the authors 0270-6474/14/346480-05$15.00/0
Author Information
- 1Preclinical Pharmacology Section of Behavioral Neuroscience Research Branch and
- 2Integrative Neurobiology Section of Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224
Author contributions
Author contributions: Z.J., S.R.G., and S.F. designed research; Z.J. and G.H.R. performed research; Z.J. analyzed data; Z.J., S.R.G., and S.F. wrote the paper.
Disclosures
- Received December 4, 2013.
- Revision received March 7, 2014.
- Accepted March 29, 2014.
This work was supported by the Intramural Research Program of the National Institute on Drug Abuse (NIDA), National Institutes of Health, Department of Health and Human Services. THC was provided by the NIDA Drug Supply Program. We thank Dr. Leigh V. Panlilio for his excellent assistance with statistical analysis.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Sergi Ferré, Integrative Neurobiology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 333 Cassell Drive, Baltimore, MD 21224. sferre{at}mail.nih.gov
